COSCIENS Biopharma Inc.

CSCI · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Assets
Cash & Equivalents$9,333$13,759$16,393$19,998
Short-Term Investments$0$0$0$0
Receivables$2,783$1,859$2,471$2,015
Inventory$1,821$2,455$2,691$3,306
Other Curr. Assets$2,566$2,282$2,426$2,902
Total Curr. Assets$16,503$20,355$23,981$28,221
Property Plant & Equip (Net)$10,923$10,660$10,966$11,807
Goodwill$0$0$0$0
Intangibles$0$0$0$1,804
Long-Term Investments$132$128$0$0
Tax Assets$0$0$0$1,077
Other NC Assets-$0$0$123$855
Total NC Assets$11,055$10,788$11,089$15,548
Other Assets$0$0$0$0
Total Assets$27,558$31,143$35,070$43,769
Liabilities
Payables$1,535$2,856$2,407$2,396
Short-Term Debt$418$506$271$405
Tax Payable$98$0$130$173
Deferred Revenue$19$122$120$46
Other Curr. Liab.$3,462$3,575$4,294$5,147
Total Curr. Liab.$5,532$7,059$7,222$8,167
LT Debt$2,049$1,973$2,039$1,211
Deferred Rev, NC$1,028$930$914$1,924
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$11,852$11,036$11,734$12,453
Total NC Liab.$14,929$13,939$14,687$15,588
Other Liabilities$0$0$0$0
Cap. Leases$2,258$2,226$2,310$1,616
Total Liabilities$20,461$20,998$21,909$23,755
Equity
Pref Stock$0$0$0$0
Common Stock$22,600$22,504$22,486$22,388
Retained Earnings-$17,227-$14,656-$12,110-$5,158
AOCI-$2,466-$1,979-$1,483-$1,553
Other Equity$4,190$4,275$4,268$4,337
Total Equity$7,097$10,144$13,161$20,014
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$27,558$31,143$35,070$43,769
Net Debt-$6,866-$11,280-$14,083-$18,382